Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
PsyBio Therapeutics
V.PSYB
Alternate Symbol(s):
PSYBF
Healthcare
Biotechnology
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of...
mental illness and neurological disorders.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:PSYB)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(70)
•••
Bookworm28
X
Comment by
Bookworm28
on Jul 13, 2022 2:06pm
RE:Meltdown?
Hmmm, now they're going to consolidate their stock on a potential/maximum basis of 1:70. I think this is the start of really good things to come. Clean out the old shareholders and bring in the
...more
(70)
•••
Bookworm28
X
Post by
Bookworm28
on Apr 15, 2022 12:54am
Meltdown?
Wow, just checking back on PSYB to see if there's anything new, and nadda. What happened to their website, and the people that were part of the research, development, and regulatory teams? What
...more
(12)
•••
lonade
X
Post by
lonade
on Mar 15, 2022 10:21am
News
PsyBio Therapeutics Announces Proposed Acquisition of Everest Pharma (Pty) Ltd., a Lesotho Company in Southern Africa, as Part of Its Ongoing Impact Investment Strategy well i have no clue what to
...more
(273)
•••
partystocker
X
Comment by
partystocker
on Jan 05, 2022 4:08pm
RE:$ORIG to ipo super soon!
With the psychedelics industry currently resting at all time lows, now probably isn't the best time for Origin to hit the market. But the positive side of this is that Origin has a great
...more
(273)
•••
partystocker
X
Post by
partystocker
on Jan 02, 2022 3:30pm
$ORIG to ipo super soon!
The more I read about Origin Therapeutics the more excited I am for them to go public. Through a portfolio including both private and public companies, it’s going to give retail investors a great
...more
(273)
•••
partystocker
X
Post by
partystocker
on Dec 29, 2021 4:36pm
Still awaiting $ORIG ipo date- but that may be a good thing
As the end of Q4 draws nearer by the hour, it appears we won’t be getting a clear IPO date from Origin therapeutics. However, as the psychedelic market continues to see all-time lows, I don’t think
...more
(273)
•••
partystocker
X
Comment by
partystocker
on Dec 23, 2021 4:34pm
RE:$ORIG- to IPO soon
Origin Therapeutics is still expected to go public before the end of Q4, giving retail investors an opportunity to invest in the private sector of the psychedelics market. With
...more
(273)
•••
partystocker
X
Post by
partystocker
on Dec 19, 2021 5:36pm
$ORIG- to IPO soon
The therapeutic psychedelic industry is expected to grow at a CAGR of 16.3% to reach a market value of $10.75 billion by 2027. The rapidly increasing acceptance of psychedelic treatments is creating a
...more
(273)
•••
partystocker
X
Post by
partystocker
on Dec 15, 2021 11:55am
$ORIG worth keeping an eye on
With public acceptance of therapeutic psychedelics increasing, there are a few companies on my radar to watch in the immediate future. With business publications starting to hop on the trend now, it’s
...more
(16)
•••
PuerSimia
X
Comment by
PuerSimia
on Dec 09, 2021 8:45pm
RE:RE:RE:Holding Pretty Good
Hey BW, bad news. Jumped back in, and regretted it. Tax loss Season, so I sold out the other week. I see most of the co's in this sector have been in decline. Hope you've been having better
...more
(273)
•••
partystocker
X
Post by
partystocker
on Dec 07, 2021 2:28pm
$ORIG Investee TripSitter Trading on CSE
Origin Therapeutics’ (soon to IPO under the ticker $ORIG) portfolio company TripSitter commenced trading on the CSE late November. Tripsitter has seen tremendous growth in the past year, and
...more
(355)
•••
Betteryear2
X
Post by
Betteryear2
on Nov 19, 2021 8:14am
Furthers Intellectual Property Portfolio
Intellectual Property Filing and Protection Remains a Top Priority OXFORD, Ohio and COCONUT CREEK, Fla., Nov. 19, 2021 /CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB
...more
(12)
•••
lonade
X
Post by
lonade
on Nov 09, 2021 7:14am
COMPASS Pathways announces positive topline results
big boost for the business model of Psybio! https://ceo.ca/@nasdaq/compass-pathways-announces-positive-topline-results
(355)
•••
Betteryear2
X
Post by
Betteryear2
on Nov 01, 2021 7:35am
Filing of Final Base Shelf Prospectus
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA/ OXFORD, Ohio and COCONUT CREEK, Fla., Nov. 1, 2021 /CNW/ -
...more
(70)
•••
Bookworm28
X
Comment by
Bookworm28
on Oct 13, 2021 4:39pm
RE:RE:Holding Pretty Good
Sorry for delayed reply PS... I'd forgottent about PSYB until today. It looks like you made the right call. They've fallen off everyone's radar. Not sure what kind of catalyst will get it
...more
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
Exclusive Insights on the Precious Metals Industry and What to Expect in 2023 – Download free report
Q2 Metals Initiates Phase Two of Exploration Work at Its Mia Lithium Property in James Bay, Quebec
Canada Nickel Continues to Intersect High-grade, Near-surface Mineralization at Texmont Project
Noble Mineral Exploration to Acquire a Mining Claim in Newfoundland Covering Approximately 175 Hectares
DehydraTECH Licensing Revenues increases 5x and Hits Another Quarterly Record with New Licensees